Skip to content
July 28-30, 2026 | Boston, MA
About
About Event
Poster Session
Content Hub
Why In Vivo Might be the Biggest Paradigm Shift for Cell and Gene Therapies
Why Ex Vivo Companies Can’t Afford to Ignore the Future of In Vivo Therapies
How Asia’s Regulatory Ecosystem Is Accelerating In Vivo Clinical Development
Benchmarking Your In Vivo Pipeline for 2026: Clinical Signals, Asia IIT Acceleration and What Top Biotechs Are Prioritizing Now
From Early Bet to Market Leader: The In Vivo CAR-T Opportunity
Interview with Stefanos Theoharis
Attendee Stories
FAQs
Events in the Series
Hanson Wade Products
What’s On?
Full Event Guide
Speakers
Agenda
Pre-Conference Day
Day One
Day Two
Why Partner
Why Partner
Partners
Media Partners
Take Part
Pricing & Registration
Venue & Accommodation
Contact Us
Event Guide
Register
About
About Event
Poster Session
Content Hub
Why In Vivo Might be the Biggest Paradigm Shift for Cell and Gene Therapies
Why Ex Vivo Companies Can’t Afford to Ignore the Future of In Vivo Therapies
How Asia’s Regulatory Ecosystem Is Accelerating In Vivo Clinical Development
Benchmarking Your In Vivo Pipeline for 2026: Clinical Signals, Asia IIT Acceleration and What Top Biotechs Are Prioritizing Now
From Early Bet to Market Leader: The In Vivo CAR-T Opportunity
Interview with Stefanos Theoharis
Attendee Stories
FAQs
Events in the Series
Hanson Wade Products
What’s On?
Full Event Guide
Speakers
Agenda
Pre-Conference Day
Day One
Day Two
Why Partner
Why Partner
Partners
Media Partners
Take Part
Pricing & Registration
Venue & Accommodation
Contact Us
July 28-30, 2026 | Boston, MA
Event Guide
Register
Vyriad
Vyriad
Scroll To Top
